Genetic Contribution to Autism and ADHD Diagnoses Shifts as Prevalence Rises
Recent research indicates that while the prevalence of autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) has increased significantly over the last two decades, the relative contribution of inherited genetic factors to these diagnoses has appeared to decline. A study published in JAMA Psychiatry suggests that as diagnostic criteria have broadened and awareness has improved, clinicians are identifying individuals with lower genetic predispositions for these neurodevelopmental conditions.
How Diagnostic Trends Influence Genetic Findings
The study, led by researchers at the Karolinska Institutet, analyzed data from over 2 million individuals born in Sweden between 1990 and 2011. Investigators observed that as the clinical threshold for diagnosing autism and ADHD lowered, the “polygenic risk score”—a measure of an individual’s cumulative genetic susceptibility—became a less accurate predictor of who would receive a diagnosis. According to the National Institute of Mental Health (NIMH), this trend aligns with the expansion of diagnostic criteria in the DSM-5, which allows for the identification of milder cases that may have previously gone undiagnosed.
Why the Genetic “Signal” Appears to Weaken
In earlier cohorts, individuals diagnosed with autism or ADHD often possessed a high concentration of rare or common genetic variants associated with these conditions. As diagnostic practices evolved to include a wider spectrum of behavioral presentations, the pool of diagnosed individuals expanded to include those with fewer genetic markers. This does not mean the underlying biology of the conditions has changed; rather, it reflects a shift in how medical systems categorize neurodevelopmental differences. The Centers for Disease Control and Prevention (CDC) notes that increased screening and public awareness have been primary drivers in the rise of reported cases since the early 2000s.
Comparing Genetic Risk Across Populations
The following table illustrates the relationship between diagnostic prevalence and genetic influence based on the longitudinal observations in the JAMA Psychiatry report:
| Factor | Historical Cohorts (Early 2000s) | Recent Cohorts (2010s-2020s) |
|---|---|---|
| Diagnostic Criteria | Strict/Narrow | Broad/Inclusive |
| Genetic Risk Score | High predictive value | Lower predictive value |
| Prevalence | Lower | Higher |
What This Means for Future Clinical Practice
The findings suggest that clinicians should remain cautious when interpreting genetic testing results for neurodevelopmental conditions. A low polygenic risk score does not rule out an autism or ADHD diagnosis, as environmental factors and polygenic interactions play a complex role in neurodevelopment. Moving forward, researchers emphasize that clinical diagnosis remains the gold standard. While genetic research provides insight into biological pathways, the broadening of diagnostic criteria serves to connect more individuals with necessary support services and interventions, according to the Autism Speaks advocacy framework.
Key Takeaways
- Broadened Criteria: The expansion of diagnostic definitions is a leading factor in the rising prevalence of autism and ADHD.
- Genetic Dilution: As more individuals are identified, the average genetic risk profile of the diagnosed population has shifted toward lower susceptibility.
- Clinical Utility: Genetic testing is not a standalone diagnostic tool, as environmental and developmental factors significantly influence the presentation of these conditions.
- Research Context: The study highlights the need for continued investigation into how societal and clinical changes impact the interpretation of genetic data in psychiatry.